Tickers

1. Composite Trajectory Verdict

Given FAST's business as a wholesale distributor with high asset turnover and consistent profitability, the income statement carries the most weight for assessing financial performance because it reflects the core operational leverage of the model.

Composite Trajectory: Improving

The composite assessment is driven by improving trends in the income statement and balance sheet, partially offset by mixed quarterly cash flow conversion. Annual results show accelerating revenue growth (+8.7% in 2025 vs +2.7% in 2024), expanding operating margin (20.2% vs 20.0%), and rising net income (+9.4%). Quarterly results confirm the trend with Q1 and Q2 2026 showing double-digit daily sales growth (12.4% and 14.7% YoY) and operating margin stability or improvement. The balance sheet shows declining debt ($200M to $125M to $120M) and rising equity ($3.6B to $3.9B to $4.1B). Cash flow is mixed: six-month operating cash flow improved 19% YoY, but Q2 2026 operating cash flow declined 4.6% YoY due to receivables growth from strong late-quarter sales.

2. Red Flags

• Gross margin compression persists across periods: annual gross margin fell 10 bps to 45.0% in 2025 (10-K 2025-12-31, Consolidated Statements of Operations); Q1 2026 gross margin fell 50 bps to 44.6% YoY (10-Q 2026-03-31, Condensed Statements of Operations); Q2 2026 gross margin fell 70 bps to 44.6% YoY (10-Q 2026-06-30, Condensed Statements of Operations).
• Quarterly operating cash flow conversion volatile: Q2 2026 operating cash flow was 79.6% of net income vs 84.3% in Q2 2025 (10-Q 2026-06-30, Condensed Statements of Cash Flows), while Q1 2026 was 111.4% vs 87.8% in Q1 2025 (10-Q 2026-03-31, Condensed Statements of Cash Flows).
• Receivables growing faster than sales: Q2 2026 receivables up 17.6% YoY vs net sales up 14.7% (10-Q 2026-06-30, MD&A Liquidity); Q1 2026 receivables up 13.0% YoY vs net sales up 12.4% (10-Q 2026-03-31, MD&A Liquidity).
• Share repurchases initiated in 2026 ($49.8M in H1 2026) after zero in 2025 and 2024 (10-Q 2026-06-30, MD&A Liquidity; 10-K 2025-12-31, MD&A Liquidity), though funded by operating cash flow and declining debt.
• Tariff refund uncertainty: Supreme Court invalidated IEEPA tariffs; refund claims submitted but amounts uncertain and no receivable recorded (10-Q 2026-06-30, MD&A Business).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Annual net sales grew 8.7% to $8,200.5M in 2025 from $7,546.0M in 2024, with daily sales up 9.1% (10-K 2025-12-31, Executive Overview). Operating income margin expanded 20 bps to 20.2% as SG&A leverage (24.8% vs 25.1%) offset 10 bps gross margin decline (10-K 2025-12-31, Consolidated Statements of Operations). Net income rose 9.4% to $1,258.4M and diluted EPS rose 9.2% to $1.09 (10-K 2025-12-31, Consolidated Statements of Operations). Quarterly trends reinforce improvement: Q1 2026 net sales +12.4% YoY, operating margin +20 bps to 20.3%, net income +13.8% (10-Q 2026-03-31, Condensed Statements of Operations). Q2 2026 net sales +14.7% YoY, operating margin flat at 21.0%, net income +15.9% (10-Q 2026-06-30, Condensed Statements of Operations). Six-month 2026 net sales +13.6%, operating margin +20 bps to 20.7%, net income +14.9% (10-Q 2026-06-30, Condensed Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow improved to $1,295.9M (104.8% of net income) in 2025 from $1,173.3M (103.0%) in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). However, quarterly patterns diverge: Q1 2026 operating cash flow surged 44.3% YoY to $378.4M (111.4% of net income) driven by inventory optimization (10-Q 2026-03-31, Condensed Statements of Cash Flows). Q2 2026 operating cash flow declined 4.6% YoY to $265.7M (79.6% of net income) due to a larger receivables build from strong late-quarter sales (10-Q 2026-06-30, Condensed Statements of Cash Flows). Six-month 2026 operating cash flow rose 19.1% to $644.1M (94.1% of net income) vs $540.8M (89.1%) in 2025 (10-Q 2026-06-30, MD&A Liquidity). Investing outflows increased modestly; financing outflows rose due to higher dividends and new share repurchases ($49.8M in H1 2026 vs $0 in H1 2025) (10-Q 2026-06-30, Condensed Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total assets grew from $4,698.0M (2024) to $5,052.9M (2025) to $5,293.5M (Q2 2026) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Balance Sheets). Total debt declined from $200.0M (2024) to $125.0M (2025) to $120.0M (Q2 2026) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Balance Sheets). Stockholders' equity rose from $3,616.3M (2024) to $3,943.6M (2025) to $4,068.8M (Q2 2026) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Balance Sheets). Trade working capital net increased 8.5% in 2025, roughly in line with sales growth (10-K 2025-12-31, MD&A Trade Working Capital Assets). Current ratio remains strong at 4.18x (Q2 2026) vs 4.85x (2025) and 4.67x (2024) (calculated from balance sheets). No near-term debt maturity concentration: $70M current portion at Q2 2026, $50M due 2027, $50M due 2030 (10-Q 2026-06-30, Note 6).

6. Data Gaps

• Standalone quarterly financial statements for Q3 2025 and Q4 2025 (only annual 2025 and comparative quarters in 2026 10-Qs are provided).
• Full quarterly cash flow statements for 2025 quarters (only annual 2025 and H1 2026/H1 2025 are provided).
• Detailed segment operating results for non-U.S. segments (only U.S. reportable segment ROA pre-tax profit disclosed) (10-K 2025-12-31, Note 10; 10-Q 2026-06-30, Note 7).
• Quarterly inventory turnover and days sales outstanding metrics (not explicitly disclosed in provided filings).
• Impact of tariff refunds on future cash flows (disclosed as uncertain, no receivable recorded) (10-Q 2026-06-30, MD&A Business).